iCampus Liberia has officially commissioned Liberia's first state-of-the-art international testing center accredited by Pearson VUE.The newly inaugurated facility marks a significant milestone in ...

The Railway Recruitment Board had invited applications for the recruitment of 5810 posts in October-November 2025.

Both the UK and US Governments have pledged to end research using animals, but is such a goal realistic? And how might it change medical research? Talha Burki reports.

The world's wealthiest man plans to launch up to a million satellites into orbit, creating vast, solar-powered data centres.

U.S. companies also plan to build solar-powered data centers in space as the market becomes crowded on Earth. When you purchase through links on our site, we may earn an affiliate commission. Here’s ...

Surging demand for energy to power artificial intelligence (AI) data centers is reaching new heights as companies are pursuing plans to station data centers in space. Billionaire entrepreneurs Elon ...

Some tech leaders are concerned that the artificial intelligence race will exhaust available land and energy. The solution might lie in orbit. Credit...Soña Lee Supported by By Eli Tan and Ryan Mac ...

To hear Silicon Valley tell it, artificial intelligence is outgrowing the planet that gave birth to it. Data centers will account for nearly half of U.S. electricity demand growth between now and 2030 ...

Aetherflux plans to launch an initial demonstration satellite to test its space-based solar power technologies by 2026. Credit: Aetherflux TAMPA, Fla. — Space-based solar power startup Aetherflux has ...

Axiom Space and Spacebilt plan to install an optically interconnected orbital data center node on the International Space Station in 2027. Credit: Axiom Space As the space industry explores orbital ...

The FDA has granted Cleveland Diagnostics’ IsoPSA test premarket approval (PMA) to help detect prostate cancer in men aged 50 years or older with elevated PSA levels. IsoPSA is a blood assay that ...

The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced. Dubbed IsoPSA, the in vitro diagnostic kit is ...